
Taiwan Semiconductor Manufacturing Company (TSMC), the leading global semiconductor producer, announced on Tuesday that it has uncovered unauthorized activities suggesting potential leaks of trade secrets. In a statement to CNBC, TSMC confirmed it has taken stringent disciplinary measures against the individuals involved and has initiated legal proceedings to address the situation. The company emphasized its unwavering stance against any conduct that jeopardizes the confidentiality of its trade secrets or undermines its business interests. "TSMC maintains a zero-tolerance policy toward such violations, which are prosecuted to the fullest extent of the law. We remain dedicated to protecting our competitive edge and the interests of all our employees," the statement read. Headquartered in Taiwan, TSMC plays a pivotal role in the production of advanced semiconductor chips, catering to major technology firms including Apple and Nvidia. Due to the ongoing legal proceedings, TSMC has limited its ability to share additional details about the case. The firm attributed its early detection of the issue to its extensive monitoring systems, which facilitated prompt internal investigations. According to Nikkei Asia, multiple sources have indicated that several former employees are under suspicion for attempting to access critical proprietary information related to the development and manufacturing of 2-nanometer chips while still employed at TSMC. The production of these next-generation 2-nanometer chips represents a significant milestone in the semiconductor industry, underscoring TSMC's importance in cutting-edge technology.
Amidst the surge of AI applications in major app stores, developers may be tempted to incorporate artificial intelligenc...
TechCrunch | Mar 10, 2026, 19:05
Microsoft has thrown its support behind Anthropic in a critical legal dispute. In a recent court filing, the tech giant ...
Business Insider | Mar 10, 2026, 23:10Oracle's stock experienced a notable increase of 8% during after-hours trading on Tuesday, following the company's relea...
CNBC | Mar 10, 2026, 20:25
In a surprising turn of events, the FDA has chosen not to approve the use of the generic drug leucovorin for treating au...
Ars Technica | Mar 10, 2026, 22:15
A coalition of industry leaders, including Google, Tesla, and data center firm Verrus, has emerged to challenge conventi...
TechCrunch | Mar 10, 2026, 21:30